
Transcend Therapeutics is a clinical-stage, neuroscience-focused company developing next-generation psychoactive medicines for neuropsychiatric disease. Transcend develops medicines that are accessible to a larger percentage of patients in need, specifically the tens of millions of patients who already take psychotropic medication. We have real-world data showing that our lead product provided significant benefit to >85% of patients with PTSD and depression. We have already advanced our lead compound into an approved Phase II study in PTSD, with plans to expand into depression and other indications.

Biotechnology

Research

Transcend Therapeutics

Transcend Therapeutics' headquarters in New York, NY, United States

Blake Mandell

Sarah Olmstead

Jennifer Schmidt

Megan Kelly

Martin Stogniew

Benjamin Kelmendi

Brenton Fargnoli

Craig Nerenberg

Lee Schalop

Kevin Ryan

Description

People (9)

Kevin Ryan

Blake Mandell

Megan Kelly

Jennifer Schmidt

Brenton Fargnoli

Stephanie Galinos

Carolyn MacLeod

Hannah Kwak

Luke Frering

Jobs